Horan Christopher

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Horan Christopher's trades of Artiva Biotherapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-18 2026-11-17 S Sale
68,469 -34.3%
403.14
US$4,036,570
68,469 -34.3% 403.14 US$4,036,570
2026-11-03 2026-11-02 S Sale
68,802 -35.6%
404.75
US$196,012
68,802 -35.6% 404.75 US$196,012
2026-10-06 2026-10-05 S Sale
28,137 -37.5%
27.48
US$2,855,803
28,137 -37.5% 27.48 US$2,855,803
2026-09-04 2026-09-03 S Sale
10,366 -3.5%
11.16
US$115,638
10,366 -3.5% 11.16 US$115,638
2026-05-19 2026-05-19 S Sale
7,002 -2.3%
9.01
US$63,073
7,002 -2.3% 9.01 US$63,073
2026-05-18 2026-05-18 PrS Proposed sale
7,500
9.22
US$69,150
7,500 9.22 US$69,150